Cheryl Z. Díaz-Barrientos, Investigación Médica, Hospital Universitario, Benemérita Universidad Autónoma de Puebla (BUAP), Puebla, México
Erick Romero-Ramos, Facultad de Medicina, Hospital Universitario, Benemérita Universidad Autónoma de Puebla (BUAP), Puebla, México
Julet Herrera-Hernández, Facultad de Medicina, Hospital Universitario, Benemérita Universidad Autónoma de Puebla (BUAP), Puebla, México
Objective: To explore the prevalence of post-coronavirus disease 2019 (COVID-19) irritable bowel syndrome (IBS) among residents of the University Hospital of Puebla. Methods: Cross-sectional survey of 34 medical residents with a previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, using Rome IV criteria to determine the prevalence of IBS. Demographic data were collected, and statistical analysis was performed using measures of central tendency and chi-square tests. Results: Among the respondents, 64.7% were men and 35.2% were women, with an average age of 30 years. The prevalence of IBS was 44.1% (95% CI: 26.8-61.4%), higher in women (67%) than in men (32%). No significant association was found between age and IBS prevalence, nor between a history of gastrointestinal symptoms during COVID-19 and the development of IBS. Conclusions: The post-COVID prevalence of IBS in the medical resident population was notable, suggesting a relevant association within this group. There was no significant association between IBS and age. More research with larger and more diverse samples is needed to better understand the risk factors for IBS.
Keywords: Irritable bowel syndrome. IBS. Prevalence. Epidemiology. Mexico. Post-COVID-19.